Skip to main content

Table 2 Summary of perioperative and follow-up outcomes

From: Single-center experience of transitioning from video-assisted laparoscopic to robotic Heller myotomy with Dor fundoplication for esophageal motility disorders

 

RHMD (N = 40)

LHMD (N = 26)

P-value

Operation time (min), median (IQR)

130 (123–141)

163 (153–169)

<0.001

Blood loss (ml), median (IQR)

42 (27–55)

51 (39–60)

0.135

Mucosal perforation, n (%)

1 (2.5%)

5 (19.2%)

0.031

Conversion to open, n (%)

0 (0.0%)

1 (3.8%)

0.394

Postoperative relief, n (%)

39 (97.5%)

25 (96.2%)

1.000

Postoperative symptoms, n (%)

   

Dysphagia

4 (10.0%)

5 (19.2%)

0.301

Regurgitation

8 (20.0%)

9 (34.6%)

0.185

Heartburn

2 (5.0%)

1 (3.8%)

1.000

Chest pain

0 (0.0%)

1 (3.8%)

0.394

Reintervention, n (%)

   

Drug therapy

20 (50.0%)

18 (69.2%)

0.122

PD

4 (10.0%)

3 (11.5%)

1.000

Heller myotomy

2 (5.0%)

1 (3.8%)

1.000

Eckardt symptom score, n (%)

  

0.557

≤ 3

39 (97.5%)

24 (92.3%)

 

> 3;

1 (2.5%)

2 (7.7%)

 
  1. IQR: interquartile range; RAHM:robotic Heller myotomy and Dor fundoplication;LHMD: video-assisted laparoscopic Heller myotomy and Dor fundoplication; PD: pneumatic dilation; Drug therapy: using calcium channel blockers or proton pump inhibitors